Introduction
Metastatic carcinoma dissemination initiates when epithelial cells in the primary tumor switch to a mesenchymal phenotype that promotes migratory behavior on planar extracellular matrix (ECM) surfaces or within three-dimensional matrices (Yilmaz and Christofori, 2009 ). This epithelial-to-mesenchymal transition increases the formation of actin-based plasma membrane protrusions, such as lamellipodia and filopodia, which have precisely defined roles in the locomotion of attached cells along a chemotactic gradient (Gupton and Gertler, 2007; Machesky, 2008) . Migratory cell types also generate protrusions of their ventral surface, such as the podosomes of monocytic and endothelial cells, whereas carcinoma cells generate invadopodia that localize proteolytic complexes to the ECM-plasma membrane interface, facilitating focal degradation and invasion (Linder, 2007; Buccione et al., 2009) .
Metastasis requires transit through the bloodstream or lymphatic vasculature to reach secondary tissues (Mendoza and Khanna, 2009) , and therefore, necessitates indefinite periods of anchorage-independent survival (Mehlen and Puisieux, 2006) . Detached tumor cells produce microtubule-rich extensions of the plasma membrane, called microtentacles (McTNs) , that promote reattachment of tumor cells to ECM and endothelial monolayers (Whipple et al., 2007 (Whipple et al., , 2008 Balzer et al., 2010) . As extravasation depends on subsequent proteolysis of the endothelial basement membrane, defining the mechanisms that support McTNs and invadopodia will strengthen our understanding of how tumor cells exit the circulation to colonize secondary tissues.
Metastatic breast carcinoma cells were selected to compare and contrast the molecular mechanisms supporting invadopodia and McTNs. We show here that MDA-MB-231 cells produce invadopodia and McTNs, both of which contain a filamentous-actin (F-actin) component. Invadopodia were increased by the expression of constitutively active c-Src protein, but strongly inhibited by dominant-negative c-Src. In contrast, dominant-negative c-Src significantly increased McTN formation, whereas a similar albeit weaker effect was observed for constitutively active Src.
This differential effect of Src on invadopodia and McTNs was further corroborated by direct inhibition of c-Src with the SU6656 inhibitor compound, which significantly enhanced McTN formation, while suppressing invadopodia. Src-transformation of NIH3T3 fibroblasts induced significant increases in both McTNs and invadopodia, whereas silencing the invadopodia-scaffolding component Tks5 blocked invadopodia, without affecting the McTN levels. To assess the biological relevance of these Src-mediated changes in protrusive morphology, in vivo lung trapping experiments were performed, which demonstrate that McTNs can increase lung retention of circulating tumor cells even in the absence of invadopodia formation. McTNs and invadopodia, therefore, arise through separate cytoskeletal mechanisms and perform distinct roles during tumor cell reattachment.
Results and discussion
The ability of circulating tumor cells to escape the bloodstream is a key determinant of metastatic efficiency (Chambers et al., 2002) , but the specific cytoskeletal mechanisms by which tumor cells successfully extravasate into distant tissues remain unclear. Given the rapid transitions in tumor cell attachment during metastasis, it is likely that the cytoskeletal dynamics of both detached and adherent tumor cells contribute to extravasation. Although adherent tumor cells form pseudopodia and invadopodia that penetrate endothelial cell junctions and remodel underlying ECM (Clark and Weaver, 2008; Miles et al., 2008) , our previous work has implicated a preceding role for McTNs during the initial engagement of detached tumor cells to the endothelium (Whipple et al., 2008; Balzer et al., 2010) . We examined the cytoskeletal mechanisms underlying invadopodia and McTNs using MDA-MB-231 metastatic human breast carcinoma cells. When allowed to attach to gelatin for 4 h, MDA-MB-231 cells formed invadopodia with characteristic Factin cores that co-aligned with degraded areas of the gelatin (Figure 1a , top row). No similar concentrations of a-tubulin could be seen within these foci (data not shown), consistent with previous reports that actin is the primary cytoskeletal component of invadopodia (Buccione et al., 2004) . To determine the structural makeup of McTNs in MDA-MB-231s, cells fixed in suspension were labeled for F-actin and a-tubulin (Figure 1a , bottom row), showing that these cells form numerous protrusions that co-stain for -tubulin and F-actin. Detached MDA-MB-231 cells, therefore, produce McTNs with an F-actin component that are structurally distinguished from invadopodia by the presence of microtubules. The same results were also observed in Bt-549 cells (Supplementry Figures S1 and S2 ).
The proto-oncogenic tyrosine kinase c-Src is both necessary and sufficient for the formation of invadopodia at sites of integrin-mediated ECM adhesion (Frame et al., 2002) . To examine the role of Src in McTN formation, we used MDA-MB-231 cells stably expressing constitutively active (c-Src527), and dominantnegative (c-Src295) c-Src variants. Significant variations in McTN production were observed for these cells (Figure 1b ). Both mutant lines exhibited increases in McTN frequency relative to the parental line, with an increase of 149% in the dominant-negative c-Src295-expressing cells, relative to the parental control. In contrast, c-Src295 repressed the formation of invadopodia, whereas c-Src527 promoted invadopodia ( Figure 1c ) that were identified by characteristic F-actin cores co-localized with phosphorylated-cortactin puncta, and digested spots in the fluorescent gelatin matrix (Linder and Aepfelbacher, 2003) . The inverse effects that dominant-negative Src has on McTNs and invadopodia indicates that separate mechanisms control these two structures. In addition, the lack of degradative capacity in the high-McTN c-Src295 line indicates that McTNs are not directly involved in proteolytic ECM degradation, suggesting that McTNs and invadopodia provide separate functions for the metastatic tumor cell.
To exclude the possibility that long-term adaptations of the c-Src295 and c-Src527 cell lines produced the varied McTN and invadopodia phenotypes, we transiently inhibited c-Src activity with the cell-permeable SU6656 inhibitor compound, which was chosen on the basis of its high affinity and selectivity for Src family kinases, relative to the PP1 and PP2 Src inhibitors, which are also potent inhibitors of PDGFR activity (Blake et al., 2000) . Treatment of c-Src527 cells with 10 mM SU6656 for 1 h suppressed the activity of c-Src, as measured by immunodetection of tyrosine-416 autophosphorylation ( Figure 2a ). As expected, the c-Src activity remained low in c-Src295 cells. Incubation with SU6656 reduced invadopodia formation (Figure 2b ), leading to reductions in ECM degradation that were strongest (21-fold) in the c-Src527 cells, which have high basal levels of invadopodia (Supplementry Figure S3) .
Having observed the suppression of invadopodia by c-Src inhibition, we proceeded to examine the effects of SU6656 on suspended MDA-MB-231 cells and both c-Src variants. Acute c-Src inhibition induced a marked increase in McTN frequency, and morphological changes characterized by dramatically augmented McTN length (Figure 2c ). Blinded quantitative scoring demonstrated that c-Src inhibition with SU6656 significantly increased McTNs in all the three cell lines (Figure 2d ). This increase was nearly four-fold above vehicle control conditions for the parental MDA-MB-231 and two-fold for c-Src527 cells. The integrity of the cortical actin cytoskeleton is an important regulator of McTN formation (Whipple et al., 2007 (Whipple et al., , 2008 Balzer et al., 2010) , therefore, increases in Src kinase activity may indirectly promote increases in McTNs formation by stimulating cytoskeletal rearrangement (Figure 2d ). It is interesting that this response occurred to an even greater extent when c-Src activity was suppressed, indicating that a lack of src signaling also results in cytoskeletal modifications that promote McTN formation. As integrin engagement is necessary for c-Src activation (Mitra and Schlaepfer, 2006) , the changes in tumor cell attachment during metastasis produce different Src activation states, as confirmed by western blotting of ECM-bound and detached cell populations (Supplementary Figure S4) . 
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Tks5/Fish, which is required for invadopodia function (Seals et al., 2005) . Src-transformed 3T3 fibroblasts expressing reduced levels of Tks5 (Figure 3a , clones 4.20 and 4.24), formed fewer invadopodia than their nonsilencing control (clones C1 and C2) and parental counterparts (Src3T3) (Figure 3b ). Src-transformed 3T3 cells exhibited McTN increases of 265% over parental controls, consistent with similar increases in cSrc527 MDA-231 cells, and c-Src inhibition in these cells further enhanced McTN frequency to nearly all cells in a given population. Moreover, no relationship could be established between invadopodia function and McTN formation, demonstrating that these two forms of cellular protrusion are mechanistically distinct (Figure 3c ). Accumulating evidence supports two broad phases through which disseminated tumor cells extravasate from systemic circulation. We propose that the early stage of this process occurs when circulating cells arrest in the vasculature and contact the endothelium. Intravital imaging studies show that initial adhesion of circulating tumor cells to capillary walls is tubulindependent, and actually enhanced by depolymerization of F-actin (Korb et al., 2004) . Recent work also demonstrates that microtubule stabilization can actually promote adhesion of suspended tumor cells to ECM (Balzer et al., 2010) . As McTNs are enriched in microtubules, and are enhanced by actin depolymerization (Whipple et al., 2007 (Whipple et al., , 2008 , these findings implicate a role for McTNs in endothelial docking during ) were tested relative to clones that express non-silencing control shRNAs (C1 and C2: lanes 3 and 4) and shRNAs complementary to Tks5/ Fish (4.20, and 4.24: lanes 5 and 6). These clones were lyzed and total protein fractions were probed for Tks5/Fish by SDS-PAGE to demonstrate efficient Tks5 knockdown. Parental 3T3 cells are represented in lane 1, and an actin loading control is shown in the bottom row. (b) Gelatin degradation of Src 3T3 Tks5 clones was assayed by immunofluorescence. Src 3T3 and Src 3T3 C1 cells efficiently and rapidly formed invadopodia by 2 h that co-localized with Tks5/Fish (inset panels, top and middle rows), whereas the Tks5 knockdown clone 4.24 showed a significant reduction in invadopodia formation and focal degradation, in agreement with previous reports (Seals et al., 2005) . (c) Microtentacle scoring over multiple independent trials (n ¼ 9) revealed an increase in McTNs among Src-transformed clones that were further enhanced by acute Src inhibition (t ¼ 30 min).
c-Src regulates microtentacles and invadopodia EM Balzer et al early extravasation. To determine the effects of c-Src modification on endothelial adhesion, dominant-negative c-Src295 and parental MDA-231 cells expressing luciferase were injected into the tail vein of mice, and imaged over a 6 h time course. The injected population was detectable in the lungs by 15 min post-injection, and was monitored over a 48-h period to allow cells to be pushed beyond the pulmonary capillary beds. The proportion of cells retained in the lungs was measured by total photon flux at select times and normalized to initial values. Figure 4 shows that suppression of c-Src activity significantly enhanced trapping and retention of circulating tumor cells in lung capillaries relative to MDA-231 parental cells. This trend was observable by 2 h, and showed significant separation over the next 46 h. In addition, both positive and negative modification of c-Src activity enhanced early rates of attachment to an extracellular substrate in vitro (Supplementry Figure S5 ). These data indicate that McTN-inducing modifications of c-Src activity promote tethering and persistence of disseminated tumor cells in secondary sites, even when invadopodia are suppressed. Trans-endothelial migration, being the second proposed phase in this model of extravasation, follows transient substrate tethering and requires a separate set of cytoplasmic functions that are dependent on permanent ECM-contact. Examples of the latter include focal adhesions and invadopodia, which are coordinated by the cell to provide the traction, tensile F-actin forces, and proteolysis of the basement membrane necessary for invasion into the surrounding stroma (Buccione et al., 2009) . Invadopodia and many other aspects of migratory cell behavior are directly regulated by c-Src, and we find that c-Src can also affect McTN formation. In light 
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